Investigation for Investors in NASDAQ:KERX Shares over Potential Wrongdoing at Keryx Biopharmaceuticals
Certain directors of Keryx Biopharmaceuticals are under investigation over potential wrongdoing. The investigation was announced for current long-term investors in NASDAQ:KERX shares over potential breaches of fiduciary duties by certain directors at Keryx Biopharmaceuticals.
View full press release